Pathogenesis and transfusion risk of transmissible spongiform encephalopathies

Developments in Biologicals

Volumn 120, Issue , 2005, Pages 27-33

  Brown, P ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NONE   (United States)

Author keywords

Creutzfeldt Jakob disease; Prion disease; Transfusion risk; Transmissible spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

BLOOD TRANSFUSION; DISEASE TRANSMISSION; HUMAN; PRION DISEASE; REVIEW; RISK FACTOR;

BLOOD TRANSFUSION; HUMANS; PRION DISEASES; RISK FACTORS;

EID: 27744595782     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (27)

1. Eklund CM, Kennedy RC, Hadlow WJ: Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 1967; 117: 15-22.
2. Hadlow WJ, Kennedy RC, Race RE: Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 1982; 146: 657-664.
3. Kimberlin RH, Walker CA: Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J Gen Virol 1980; 51: 183-187.
4. Kimberlin RH, Walker CA: Pathogenesis of scrapie in mice after intragastric infection. Virus Res 1989; 12: 213-200.
5. van Keulen LJM, Schreuder BEC, Vromans MEW, Langeveld JPM, Smits MA: Pathogenesis of natural scrapie in sheep. Archives of Virology (Supplement) 2000; 16: 57-71.
6. Race RR, Oldstone M, Chesebro B: Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. Journal of Virology 2000; 74: 828-833.
7. Brown P: The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades. Cell Molec Life Sci 2003; 58: 259-265.
8. WHO Guidelines on Transmissible Spongiform Encephalopathies in relation to Biological and Pharmaceutical Products. Annex On line at WHO website: http://www.who.int/biologicals.
9. Brown KL, Stewart K, Ritchie DL, et al: Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 1999; 5: 1308-1312.
10. Beekes M, McBride PA: Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci Lett 2000; 278: 181-184.
11. Beekes M, McBride PA, Baldauf E: Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 1998; 79: 601-607.
12. Fraser H: Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature 1982; 295: 149-150.
13. Ingrosso L, Pisani F, Pocchiari: Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999; 80: 3043-3047.
14. Bartz JC, Kincaid AE, Bessen RA: Rapid prion neuroinvasion following tongue infection. J Virol 2003; 77: 583-591.
15. Zanusso G, Ferrari S, Cardone F, et al: Detection of pathological prion protein in the olfactory epithelium of sporadic Creutzfeldt-Jakob disease subjects. New Engl J Med 2003; 348: 711-719.
16. Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WN: Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999; 39: 1169-1178.
17. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P: Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci (USA) 1999; 96: 4046-4051.
18. th Annual Meeting "Blood Product Safety: TSE, Perception versus Reality", MacLean, Virginia, February 13-15, 2000.
19. Hunter N, Foster J, Chong A, et al: Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83: 2897-2905.
20. Foster PR, Welch AG, McLean C, et al: Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sang 2000; 78: 86-95.
21. Stenland CJ, Lee DC, Brown P, Petteway SR Jr, Rubenstein R: Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma. Transfusion 2002; 42: 1497-1500.
22. Will RG, Ironside JW, Zeidler M, et al: A new variant of Creutzfeldt-Jakob disease. Lancet 1996; 347: 21-925.
23. Brown P: Variant CJD transmission through blood: risks to predictors and "predictees". Transfusion 2003; 43: 425-427.
24. Llewelyn CA, Hewitt PE, Knight RSG, et al: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
25. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW: Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 529-531.
26. Bruce ME, McConnell I, Will RG, Ironside JW: Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208-209.
27. Cervenakova L, Yakovleva O, McKenzie C, et al: Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43: 1687-1694.